Robert D. Schreiber, PhD; Philip D. Greenberg, MD; and Nathan Cherny, MBBS, are highlighted.

Robert D. Schreiber

Philip D. Greenberg

Robert D. Schreiber, PhD, and Philip D. Greenberg, MD, have been named editors-in-chief of Cancer Immunology Research, a peer-reviewed journal launched in 2013 by the American Association for Cancer Research. The journal publishes original articles reporting advances in cancer immunology and immunotherapies, from basic investigations to early translational studies and late-stage clinical trials. Schreiber and Greenberg succeed Glenn Dranoff, MD.

Schreiber is a professor of pathology and immunology and director of the Center for Human Immunology and Immunotherapy Programs at Washington University School of Medicine in St. Louis, MO. He and his colleagues have identified somatic mutations in tumors that give rise to tumor-specific mutant antigens.

Greenberg is a professor of medicine/oncology and immunology at the University of Washington and head of the Program in Immunology at the Fred Hutchinson Cancer Research Center in Seattle. He has studied the principles underlying a T cell's ability to recognize and eliminate tumor cells, distinguish cancer cells from normal ones, and maintain their function in the tumor microenvironment.

The European Society for Medical Oncology (ESMO) bestowed its ESMO Award upon Nathan Cherny, MBBS, at the European Cancer Congress in Vienna, Austria, at the end of September. The award recognizes the key role he has played in integrating palliative care into the practice of oncology, such as developing training programs for oncologists and setting minimum standards for palliative care in cancer centers. Cherny is the director of the Cancer Pain and Palliative Care Service at Shaare Zedek Medical Center in Jerusalem, Israel.

For more news on cancer research, visit Cancer Discovery online at